Vrnda Pharma Private Limited - Charges

Every charge - open or closed - that lenders have registered against Vrnda Pharma Private Limited, with the most recent activity at the top.

2016-08-01 Mumbai, Maharashtra Active Unlisted Active Compliant
Share
Connect MCP
VP Vrnda Pharma Private Limited
Open charges
6
3.32 cr
Closed charges
0
0.00
Total
6
3.32 cr
Open vs closed
Top charge holders (by amount)
Top lenders
#LenderChargesAmount
1 Others 6 3.32 cr
All charges (6) - latest first
Charge ID Charge holder Created Modified Satisfied Amount Status
100888777 Others 01 Mar 2024 - - 35.00 Lakh Open
100646228 Others 05 Dec 2022 - - 56.00 Lakh Open
100645464 Others 30 Nov 2022 - - 62.00 Lakh Open
100623072 Others 21 Oct 2022 25 Aug 2023 - 95.00 Lakh Open
100211270 Others 08 Oct 2018 - - 50.00 Lakh Open
100130246 Others 11 Oct 2017 - - 34.00 Lakh Open
Frequently Asked Questions - Charges & borrowings
What do "charges" mean for Vrnda Pharma Private Limited?
Charges are registrable security interests-typically loans or credit facilities-filed with MCA against Vrnda Pharma Private Limited (CIN: U51909MH2016PTC284291). They indicate assets or undertakings pledged to lenders or charge holders.
What is the difference between open and closed charges?
Open charges are active or not yet fully discharged; closed (or satisfied) charges are recorded as settled or released. Counts and amounts on this page follow the statuses shown in the charge list.
How should I read the open vs closed amounts?
Open and closed amounts summarise registrable amounts by status for quick comparison; individual rows may show charge-specific amounts, holders, and dates for verification.
Who are the "top lenders" or charge holders?
Top lenders group charge holders by bank or institution name and approximate exposure so you can see which lenders appear most prominently for Vrnda Pharma Private Limited.
Where can I cross-check financial or ownership context?
Pair this Charges view with the Financial and Ownership sections on this company's V1 profile for loans in financial statements and cap table context alongside MCA charge filings.